Blood and sputum tests to predict recovery in ARDS patients
Part of Lungs & breathing clinical trials.
This study looks at blood and sputum samples from people with ARDS (a serious lung condition) to find clues that might predict how well they will recover. The goal is to improve care and outcomes for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have ARDS, a severe lung condition, as diagnosed by a doctor
- Your condition is stable for at least 12 to 24 hours before joining
- You have low oxygen levels in your blood (PaO2/FiO2 ≤ 300 mmHg)
- You do not have major chronic lung disease or a weakened immune system
- You are able to give blood and sputum (mucus from your lungs) samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study looks at how certain proteins in the body affect lung healing in older adults after ARDS. It aims to find ways to improve recovery from this serious breathing condition.
This study looks at the real-world features, treatments, and outcomes of people with acute respiratory distress syndrome (ARDS), a serious lung condition that makes it hard to breathe. If you are on certain types of breathing support and meet the oxygen and lung scan criteria, your participation may help improve care for others with this condition.
This study looks at how severe lung injury (ARDS) affects brain and nerve function. It aims to find ways to improve recovery and quality of life for patients who have been in intensive care.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
Hear when a new Microbiome Dysbiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.